Skip to main content
. Author manuscript; available in PMC: 2018 Apr 15.
Published in final edited form as: Int J Cancer. 2017 Apr 15;140(8):1899–1906. doi: 10.1002/ijc.30566

Figure II. Overall survival by EBV status prior to treatment.

Figure II

A) Overall survival by pEBVd status prior to therapy. pEBVd+ defined as >2000 copies/mL by a clinical qRT-PCR. B) Overall survival according to EBER and pEBVd status. There were no EBER− pEBVd+ patients